{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:56:25Z","timestamp":1767851785904,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1476-4598-13-229","type":"journal-article","created":{"date-parts":[[2014,10,6]],"date-time":"2014-10-06T05:01:39Z","timestamp":1412571699000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["microRNA regulation of mammalian target of rapamycin expression and activity controls estrogen receptor function and RAD001 sensitivity"],"prefix":"10.1186","volume":"13","author":[{"given":"Elizabeth C","family":"Martin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyndsay V","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrienne E","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth P","family":"Nephew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik K","family":"Flemington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridgette M","family":"Collins-Burow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew E","family":"Burow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,6]]},"reference":[{"key":"1435_CR1","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.cellsig.2009.01.012","volume":"21","author":"EA Dunlop","year":"2009","unstructured":"Dunlop EA, Tee AR: Mammalian target of rapamycin complex 1: signalling inputs, substrates and feedback mechanisms. Cellular signalling. 2009, 21: 827-835. 10.1016\/j.cellsig.2009.01.012","journal-title":"Cellular signalling"},{"key":"1435_CR2","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1126\/science.1187532","volume":"328","author":"RJ Dowling","year":"2010","unstructured":"Dowling RJ, Topisirovic I, Alain T, Bidinosti M, Fonseca BD, Petroulakis E, Wang X, Larsson O, Selvaraj A, Liu Y, Kozma SC, Thomas G, Sonenberg N: mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs. Science. 2010, 328: 1172-1176. 10.1126\/science.1187532","journal-title":"Science"},{"key":"1435_CR3","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1158\/0008-5472.CAN-10-4058","volume":"71","author":"P Gulhati","year":"2011","unstructured":"Gulhati P, Bowen KA, Liu J, Stevens PD, Rychahou PG, Chen M, Lee EY, Weiss HL, O'Connor KL, Gao T, Evers BM: mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. Cancer research. 2011, 71: 3246-3256. 10.1158\/0008-5472.CAN-10-4058","journal-title":"Cancer research"},{"key":"1435_CR4","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1101\/gad.1212704","volume":"18","author":"N Hay","year":"2004","unstructured":"Hay N, Sonenberg N: Upstream and downstream of mTOR. Genes & development. 2004, 18: 1926-1945. 10.1101\/gad.1212704","journal-title":"Genes & development"},{"key":"1435_CR5","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim J, Kundu M, Viollet B, Guan KL: AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nature cell biology. 2011, 13: 132-141. 10.1038\/ncb2152","journal-title":"Nature cell biology"},{"key":"1435_CR6","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.molcel.2010.09.026","volume":"40","author":"S Sengupta","year":"2010","unstructured":"Sengupta S, Peterson TR, Sabatini DM: Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Molecular cell. 2010, 40: 310-322. 10.1016\/j.molcel.2010.09.026","journal-title":"Molecular cell"},{"key":"1435_CR7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1042\/BST0370217","volume":"37","author":"J Huang","year":"2009","unstructured":"Huang J, Manning BD: A complex interplay between Akt, TSC2 and the two mTOR complexes. Biochemical Society transactions. 2009, 37: 217-222. 10.1042\/BST0370217","journal-title":"Biochemical Society transactions"},{"key":"1435_CR8","doi-asserted-by":"publisher","first-page":"4104","DOI":"10.1128\/MCB.00289-08","volume":"28","author":"J Huang","year":"2008","unstructured":"Huang J, Dibble CC, Matsuzaki M, Manning BD: The TSC1-TSC2 complex is required for proper activation of mTOR complex 2. Molecular and cellular biology. 2008, 28: 4104-4115. 10.1128\/MCB.00289-08","journal-title":"Molecular and cellular biology"},{"key":"1435_CR9","doi-asserted-by":"publisher","first-page":"6107","DOI":"10.1158\/0008-5472.CAN-09-0975","volume":"69","author":"J Huang","year":"2009","unstructured":"Huang J, Wu S, Wu CL, Manning BD: Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors. Cancer research. 2009, 69: 6107-6114.","journal-title":"Cancer research"},{"key":"1435_CR10","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1128\/MCB.00601-09","volume":"30","author":"LA Julien","year":"2010","unstructured":"Julien LA, Carriere A, Moreau J, Roux PP: mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling. Molecular and cellular biology. 2010, 30: 908-921. 10.1128\/MCB.00601-09","journal-title":"Molecular and cellular biology"},{"key":"1435_CR11","first-page":"3065","volume":"118","author":"A Carracedo","year":"2008","unstructured":"Carracedo A, Ma L, Teruya-Feldstein J, Rojo F, Salmena L, Alimonti A, Egia A, Sasaki AT, Thomas G, Kozma SC, Papa A, Nardella C, Cantley LC, Baselga J, Pandolfi PP: Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. The Journal of clinical investigation. 2008, 118: 3065-3074.","journal-title":"The Journal of clinical investigation"},{"key":"1435_CR12","doi-asserted-by":"publisher","first-page":"8204","DOI":"10.1073\/pnas.0502857102","volume":"102","author":"Z Feng","year":"2005","unstructured":"Feng Z, Zhang H, Levine AJ, Jin S: The coordinate regulation of the p53 and mTOR pathways in cells. Proceedings of the National Academy of Sciences of the United States of America. 2005, 102: 8204-8209. 10.1073\/pnas.0502857102","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"1435_CR13","doi-asserted-by":"publisher","first-page":"7721","DOI":"10.1200\/JCO.2005.09.004","volume":"23","author":"X Cui","year":"2005","unstructured":"Cui X, Schiff R, Arpino G, Osborne CK, Lee AV: Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005, 23: 7721-7735. 10.1200\/JCO.2005.09.004","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"key":"1435_CR14","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1210\/me.2002-0318","volume":"17","author":"X Cui","year":"2003","unstructured":"Cui X, Zhang P, Deng W, Oesterreich S, Lu Y, Mills GB, Lee AV: Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase\/Akt\/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer. Molecular endocrinology. 2003, 17: 575-588. 10.1210\/me.2002-0318","journal-title":"Molecular endocrinology"},{"key":"1435_CR15","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1210\/me.2010-0373","volume":"25","author":"MA Becker","year":"2011","unstructured":"Becker MA, Ibrahim YH, Cui X, Lee AV, Yee D: The IGF pathway regulates ERalpha through a S6K1-dependent mechanism in breast cancer cells. Molecular endocrinology. 2011, 25: 516-528. 10.1210\/me.2010-0373","journal-title":"Molecular endocrinology"},{"key":"1435_CR16","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.1158\/1078-0432.CCR-04-2402","volume":"11","author":"A Boulay","year":"2005","unstructured":"Boulay A, Rudloff J, Ye J, Zumstein-Mecker S, O'Reilly T, Evans DB, Chen S, Lane HA: Dual inhibition of mTOR and estrogen receptor signaling in vitro induces cell death in models of breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2005, 11: 5319-5328. 10.1158\/1078-0432.CCR-04-2402","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"key":"1435_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jss.2006.07.003","volume":"138","author":"SB Chang","year":"2007","unstructured":"Chang SB, Miron P, Miron A, Iglehart JD: Rapamycin inhibits proliferation of estrogen-receptor-positive breast cancer cells. The Journal of surgical research. 2007, 138: 37-44. 10.1016\/j.jss.2006.07.003","journal-title":"The Journal of surgical research"},{"key":"1435_CR18","doi-asserted-by":"publisher","first-page":"D949","DOI":"10.1093\/nar\/gks1008","volume":"41","author":"M Goldman","year":"2013","unstructured":"Goldman M, Craft B, Swatloski T, Ellrott K, Cline M, Diekhans M, Ma S, Wilks C, Stuart J, Haussler D, Zhu J: The UCSC Cancer Genomics Browser: update 2013. Nucleic acids research. 2013, 41: D949-954. 10.1093\/nar\/gks1008","journal-title":"Nucleic acids research"},{"key":"1435_CR19","doi-asserted-by":"publisher","first-page":"D951","DOI":"10.1093\/nar\/gkq1113","volume":"39","author":"JZ Sanborn","year":"2011","unstructured":"Sanborn JZ, Benz SC, Craft B, Szeto C, Kober KM, Meyer L, Vaske CJ, Goldman M, Smith KE, Kuhn RM, Karolchik D, Kent WJ, Stuart JM, Haussler D, Zhu J: The UCSC Cancer Genomics Browser: update 2011. Nucleic acids research. 2011, 39: D951-959. 10.1093\/nar\/gkq1113","journal-title":"Nucleic acids research"},{"key":"1435_CR20","doi-asserted-by":"publisher","first-page":"i237","DOI":"10.1093\/bioinformatics\/btq182","volume":"26","author":"CJ Vaske","year":"2010","unstructured":"Vaske CJ, Benz SC, Sanborn JZ, Earl D, Szeto C, Zhu J, Haussler D, Stuart JM: Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics. 2010, 26: i237-245. 10.1093\/bioinformatics\/btq182","journal-title":"Bioinformatics"},{"key":"1435_CR21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nmeth0409-239","volume":"6","author":"J Zhu","year":"2009","unstructured":"Zhu J, Sanborn JZ, Benz S, Szeto C, Hsu F, Kuhn RM, Karolchik D, Archie J, Lenburg ME, Esserman LJ, Kent WJ, Haussler D, Wang T: The UCSC Cancer Genomics Browser. Nature methods. 2009, 6: 239-240. 10.1038\/nmeth0409-239","journal-title":"Nature methods"},{"key":"1435_CR22","doi-asserted-by":"publisher","first-page":"bas060","DOI":"10.1093\/database\/bas060","volume":"2013","author":"P Jezequel","year":"2013","unstructured":"Jezequel P, Frenel JS, Campion L, Guerin-Charbonnel C, Gouraud W, Ricolleau G, Campone M:bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses. Database: the journal of biological databases and curation. 2013, 2013: bas060-","journal-title":"Database: the journal of biological databases and curation"},{"key":"1435_CR23","doi-asserted-by":"publisher","first-page":"e49067","DOI":"10.1371\/journal.pone.0049067","volume":"7","author":"EC Martin","year":"2012","unstructured":"Martin EC, Bratton MR, Zhu Y, Rhodes LV, Tilghman SL, Collins-Burow BM, Burow ME: Insulin-like growth factor-1 signaling regulates miRNA expression in MCF-7 breast cancer cell line. PloS one. 2012, 7: e49067- 10.1371\/journal.pone.0049067","journal-title":"PloS one"},{"key":"1435_CR24","doi-asserted-by":"publisher","first-page":"D674","DOI":"10.1093\/nar\/gkn653","volume":"37","author":"CF Schaefer","year":"2009","unstructured":"Schaefer CF, Anthony K, Krupa S, Buchoff J, Day M, Hannay T, Buetow KH: PID: the Pathway Interaction Database. Nucleic acids research. 2009, 37: D674-679. 10.1093\/nar\/gkn653","journal-title":"Nucleic acids research"},{"key":"1435_CR25","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1158\/1541-7786.MCR-13-0212","volume":"11","author":"X Chen","year":"2013","unstructured":"Chen X, Zhao M, Hao M, Sun X, Wang J, Mao Y, Zu L, Liu J, Shen Y, Wang J, Shen K: Dual inhibition of PI3K and mTOR mitigates compensatory AKT activation and improves tamoxifen response in breast cancer. Molecular cancer research : MCR. 2013, 11: 1269-1278. 10.1158\/1541-7786.MCR-13-0212","journal-title":"Molecular cancer research : MCR"},{"key":"1435_CR26","doi-asserted-by":"publisher","first-page":"D613","DOI":"10.1093\/nar\/gkp939","volume":"38","author":"B Rhead","year":"2010","unstructured":"Rhead B, Karolchik D, Kuhn RM, Hinrichs AS, Zweig AS, Fujita PA, Diekhans M, Smith KE, Rosenbloom KR, Raney BJ, Pohl A, Pheasant M, Meyer LR, Learned K, Hsu F, Hillman-Jackson J, Harte RA, Giardine B, Dreszer TR, Clawson H, Barber GP, Haussler D, Kent WJ: The UCSC Genome Browser database: update 2010. Nucleic acids research. 2010, 38: D613-619.","journal-title":"Nucleic acids research"},{"key":"1435_CR27","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nature07509","volume":"456","author":"ET Wang","year":"2008","unstructured":"Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB: Alternative isoform regulation in human tissue transcriptomes. Nature. 2008, 456: 470-476. 10.1038\/nature07509","journal-title":"Nature"},{"key":"1435_CR28","first-page":"289","volume":"6","author":"CJ Creighton","year":"2012","unstructured":"Creighton CJ: The molecular profile of luminal B breast cancer. Biologics: targets & therapy. 2012, 6: 289-297.","journal-title":"Biologics: targets & therapy"},{"key":"1435_CR29","doi-asserted-by":"publisher","first-page":"1013s","DOI":"10.1158\/1078-0432.CCR-05-2128","volume":"12","author":"HJ Kim","year":"2006","unstructured":"Kim HJ, Cui X, Hilsenbeck SG, Lee AV:Progesterone receptor loss correlates with human epidermal growth factor receptor 2 overexpression in estrogen receptor-positive breast cancer. Clinical cancer research: an official journal of the American Association for Cancer Research. 2006, 12: 1013s-1018s. 10.1158\/1078-0432.CCR-05-2128","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"1435_CR30","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3892\/ol.2012.841","volume":"4","author":"Z Lu","year":"2012","unstructured":"Lu Z, Ye Y, Jiao D, Qiao J, Cui S: Liu Z: miR-155 and miR-31 are differentially expressed in breast cancer patients and are correlated with the estrogen receptor and progesterone receptor status. Oncology letters. 2012, 4: 1027-1032.","journal-title":"Oncology letters"},{"key":"1435_CR31","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.devcel.2010.03.008","volume":"18","author":"CC Chen","year":"2010","unstructured":"Chen CC, Jeon SM, Bhaskar PT, Nogueira V, Sundararajan D, Tonic I, Park Y, Hay N: FoxOs inhibit mTORC1 and activate Akt by inducing the expression of Sestrin3 and Rictor. Developmental cell. 2010, 18: 592-604. 10.1016\/j.devcel.2010.03.008","journal-title":"Developmental cell"},{"key":"1435_CR32","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","volume":"14","author":"DD Sarbassov","year":"2004","unstructured":"Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument-Bromage H, Tempst P, Sabatini DM: Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Current biology : CB. 2004, 14: 1296-1302. 10.1016\/j.cub.2004.06.054","journal-title":"Current biology : CB"},{"issue":"Suppl 3","key":"1435_CR33","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/S0960-9776(09)70266-8","volume":"18","author":"VC Jordan","year":"2009","unstructured":"Jordan VC, Lewis-Wambi JS, Patel RR, Kim H, Ariazi EA: New hypotheses and opportunities in endocrine therapy: amplification of oestrogen-induced apoptosis. Breast. 2009, 18 (Suppl 3): S10-17.","journal-title":"Breast"},{"key":"1435_CR34","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1053\/j.gastro.2008.10.029","volume":"136","author":"WH Liu","year":"2009","unstructured":"Liu WH, Yeh SH, Lu CC, Yu SL, Chen HY, Lin CY, Chen DS, Chen PJ: MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells. Gastroenterology. 2009, 136: 683-693. 10.1053\/j.gastro.2008.10.029","journal-title":"Gastroenterology"},{"key":"1435_CR35","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/onc.2010.487","volume":"30","author":"X Rao","year":"2011","unstructured":"Rao X, Di Leva G, Li M, Fang F, Devlin C, Hartman-Frey C, Burow ME, Ivan M, Croce CM, Nephew KP: MicroRNA-221\/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways. Oncogene. 2011, 30: 1082-1097. 10.1038\/onc.2010.487","journal-title":"Oncogene"},{"key":"1435_CR36","doi-asserted-by":"publisher","first-page":"31079","DOI":"10.1074\/jbc.M806041200","volume":"283","author":"JJ Zhao","year":"2008","unstructured":"Zhao JJ, Lin J, Yang H, Kong W, He L, Ma X, Coppola D, Cheng JQ: MicroRNA-221\/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. The Journal of biological chemistry. 2008, 283: 31079-31086. 10.1074\/jbc.M806041200","journal-title":"The Journal of biological chemistry"},{"key":"1435_CR37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s11010-013-1642-6","volume":"379","author":"C Zhang","year":"2013","unstructured":"Zhang C, Zhao J, Deng H: 17beta-estradiol up-regulates miR-155 expression and reduces TP53INP1 expression in MCF-7 breast cancer cells. Molecular and cellular biochemistry. 2013, 379: 201-211. 10.1007\/s11010-013-1642-6","journal-title":"Molecular and cellular biochemistry"},{"key":"1435_CR38","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1158\/0008-5472.CAN-09-4250","volume":"70","author":"S Jiang","year":"2010","unstructured":"Jiang S, Zhang HW, Lu MH, He XH, Li Y, Gu H, Liu MF, Wang ED: MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer research. 2010, 70: 3119-3127. 10.1158\/0008-5472.CAN-09-4250","journal-title":"Cancer research"},{"key":"1435_CR39","doi-asserted-by":"publisher","first-page":"17869","DOI":"10.1074\/jbc.M110.101055","volume":"285","author":"W Kong","year":"2010","unstructured":"Kong W, He L, Coppola M, Guo J, Esposito NN, Coppola D, Cheng JQ: MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. The Journal of biological chemistry. 2010, 285: 17869-17879. 10.1074\/jbc.M110.101055","journal-title":"The Journal of biological chemistry"},{"key":"1435_CR40","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.ygyno.2010.07.021","volume":"119","author":"F Wang","year":"2010","unstructured":"Wang F, Zheng Z, Guo J, Ding X: Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor. Gynecologic oncology. 2010, 119: 586-593. 10.1016\/j.ygyno.2010.07.021","journal-title":"Gynecologic oncology"},{"key":"1435_CR41","doi-asserted-by":"publisher","first-page":"e1003697","DOI":"10.1371\/journal.ppat.1003697","volume":"9","author":"J Wang","year":"2013","unstructured":"Wang J, Yang K, Zhou L, Minhaowu A, Wu Y, Zhu M, Lai X, Chen T, Feng L, Li M, Huang C, Zhong Q, Huang X:MicroRNA-155 promotes autophagy to eliminate intracellular mycobacteria by targeting Rheb. PLoS pathogens. 2013, 9: e1003697- 10.1371\/journal.ppat.1003697","journal-title":"PLoS pathogens"},{"key":"1435_CR42","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4161\/auto.26534","volume":"10","author":"G Wan","year":"2014","unstructured":"Wan G, Xie W, Liu Z, Xu W, Lao Y, Huang N, Cui K, Liao M, He J, Jiang Y, Yang BB, Xu H, Xu N, Zhang Y: Hypoxia-induced MIR155 is a potent autophagy inducer by targeting multiple players in the MTOR pathway. Autophagy. 2014, 10: 70-79. 10.4161\/auto.26534","journal-title":"Autophagy"},{"key":"1435_CR43","doi-asserted-by":"publisher","first-page":"7159","DOI":"10.1158\/1078-0432.CCR-06-1426","volume":"12","author":"VA Salvo","year":"2006","unstructured":"Salvo VA, Boue SM, Fonseca JP, Elliott S, Corbitt C, Collins-Burow BM, Curiel TJ, Srivastav SK, Shih BY, Carter-Wientjes C, Wood CE, Erhardy PW, Beckman BS, McLachlan JA, Cleveland TE, Burow ME: Antiestrogenic glyceollins suppress human breast and ovarian carcinoma tumorigenesis. Clinical cancer research : an official journal of the American Association for Cancer Research. 2006, 12: 7159-7164. 10.1158\/1078-0432.CCR-06-1426","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"key":"1435_CR44","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1006\/abio.2000.4753","volume":"285","author":"TD Schmittgen","year":"2000","unstructured":"Schmittgen TD, Zakrajsek BA, Mills AG, Gorn V, Singer MJ, Reed MW: Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Analytical biochemistry. 2000, 285: 194-204. 10.1006\/abio.2000.4753","journal-title":"Analytical biochemistry"},{"key":"1435_CR45","doi-asserted-by":"publisher","first-page":"5295","DOI":"10.1128\/JVI.02380-07","volume":"82","author":"Q Yin","year":"2008","unstructured":"Yin Q, McBride J, Fewell C, Lacey M, Wang X, Lin Z, Cameron J, Flemington EK: MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways. Journal of virology. 2008, 82: 5295-5306. 10.1128\/JVI.02380-07","journal-title":"Journal of virology"},{"key":"1435_CR46","doi-asserted-by":"publisher","first-page":"e1003222","DOI":"10.1371\/journal.ppat.1003222","volume":"9","author":"J Marsolier","year":"2013","unstructured":"Marsolier J, Pineau S, Medjkane S, Perichon M, Yin Q, Flemington E, Weitzman MD, Weitzman JB: OncomiR addiction is generated by a miR-155 feedback loop in Theileria-transformed leukocytes. PLoS pathogens. 2013, 9: e1003222- 10.1371\/journal.ppat.1003222","journal-title":"PLoS pathogens"},{"key":"1435_CR47","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1186\/bcr3192","volume":"14","author":"CR Tate","year":"2012","unstructured":"Tate CR, Rhodes LV, Segar HC, Driver JL, Pounder FN, Burow ME, Collins-Burow BM: Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat. Breast cancer research: BCR. 2012, 14: R79- 10.1186\/bcr3192","journal-title":"Breast cancer research: BCR"},{"key":"1435_CR48","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s10549-011-1457-7","volume":"131","author":"P Jezequel","year":"2012","unstructured":"Jezequel P, Campone M, Gouraud W, Guerin-Charbonnel C, Leux C, Ricolleau G: Campion L: bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer. Breast cancer research and treatment. 2012, 131: 765-775. 10.1007\/s10549-011-1457-7","journal-title":"Breast cancer research and treatment"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-4598-13-229.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T06:10:14Z","timestamp":1630563014000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/1476-4598-13-229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,6]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1435"],"URL":"https:\/\/doi.org\/10.1186\/1476-4598-13-229","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,6]]},"assertion":[{"value":"28 May 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"229"}}